Covalon Technologies Ltd. - Asset Resilience Ratio
Covalon Technologies Ltd. (COV) has an Asset Resilience Ratio of 6.33% as of December 2015. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Covalon Technologies Ltd. (COV) financial obligations for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2007–2016)
This chart shows how Covalon Technologies Ltd.'s Asset Resilience Ratio has changed over time. See COV net asset value for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Covalon Technologies Ltd.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market value of Covalon Technologies Ltd..
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CA$0.00 | 0% |
| Short-term Investments | CA$548.06K | 6.33% |
| Total Liquid Assets | CA$548.06K | 6.33% |
Asset Resilience Insights
- Limited Liquidity: Covalon Technologies Ltd. maintains only 6.33% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Covalon Technologies Ltd. Industry Peers by Asset Resilience Ratio
Compare Covalon Technologies Ltd.'s asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Alcon AG
SW:ALC |
Medical Instruments & Supplies | 0.26% |
|
iRay Technology Co Ltd
SHG:688301 |
Medical Instruments & Supplies | 0.68% |
|
Anbio Biotechnology Class A Ordinary Shares
NASDAQ:NNNN |
Medical Instruments & Supplies | 29.19% |
|
Jiangsu Nanfang Medical
SHG:603880 |
Medical Instruments & Supplies | 2.27% |
|
SDI Ltd
AU:SDI |
Medical Instruments & Supplies | 6.36% |
|
I.Ceram SA
PA:ALICR |
Medical Instruments & Supplies | -1.61% |
|
Ansell Ltd
AU:ANN |
Medical Instruments & Supplies | 4.42% |
|
Nanosonics Ltd
AU:NAN |
Medical Instruments & Supplies | 51.82% |
Annual Asset Resilience Ratio for Covalon Technologies Ltd. (2007–2016)
The table below shows the annual Asset Resilience Ratio data for Covalon Technologies Ltd..
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2016-09-30 | 0.00% | CA$0.00 ≈ $0.00 |
CA$6.49 Million ≈ $4.69 Million |
-- |
| 2015-09-30 | 7.17% | CA$547.04K ≈ $395.72K |
CA$7.63 Million ≈ $5.52 Million |
+0.37pp |
| 2014-09-30 | 6.80% | CA$541.00K ≈ $391.35K |
CA$7.96 Million ≈ $5.76 Million |
-2.02pp |
| 2013-09-30 | 8.82% | CA$500.00K ≈ $361.69K |
CA$5.67 Million ≈ $4.10 Million |
+0.43pp |
| 2012-09-30 | 8.38% | CA$500.00K ≈ $361.69K |
CA$5.96 Million ≈ $4.31 Million |
+3.02pp |
| 2011-09-30 | 5.36% | CA$500.00K ≈ $361.69K |
CA$9.32 Million ≈ $6.74 Million |
+0.52pp |
| 2010-09-30 | 4.85% | CA$500.00K ≈ $361.69K |
CA$10.32 Million ≈ $7.47 Million |
+0.96pp |
| 2009-09-30 | 3.89% | CA$500.00K ≈ $361.69K |
CA$12.87 Million ≈ $9.31 Million |
-48.64pp |
| 2008-09-30 | 52.52% | CA$9.08 Million ≈ $6.57 Million |
CA$17.29 Million ≈ $12.51 Million |
+6.82pp |
| 2007-09-30 | 45.70% | CA$9.25 Million ≈ $6.69 Million |
CA$20.24 Million ≈ $14.64 Million |
-- |
About Covalon Technologies Ltd.
Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, the Middle East, Canada, Latin America, Asia, and internationally. The company's platform technologies comprises collagen matrix platform that is used to manufacture a family of products to… Read more